Thanks for the feedback. The sample size was very small if you look at the glassdoor reviews over the past few years, so not exactly scientific. I don't obsess over glassdoor or indeed reviews or ratings but I like to look at it as a data point just to make sure it is not a red flag. As a Motley Fool and Phil Fisher acolyte, employee relations is always something that is in the back of my mind. Anyways, I just opened up a 2% starter position in TMDX. I like the MOAT, mission, and execution. I've watched from the sidelines for a while but the execution is impressive. Another question. What is your opinion of Jonah Lupton, if any? I've read a few of his articles on seeking alpha and recently subscribed to the free previews of his newsletter.
I follow Jonah on Twitter and have read a couple of his writeups, but it mostly been observation from afar. As an investor, he's a little too trading-heavy for my style (I'm not much into charts or hedging).
I am doing due diligence on transmedics and noticed poor glassdoor ratings, only 52% approved of the CEO and only 41% would recommend to a friend. Overall 2.7 stars. What is your opinion of employee relations and management?
Over the years I've seen various people incorporate these types of rankings into their investment decisions. However, I've never been able to find a pattern that's actionable. I've owned companies with great approval ratings that have been terrible investments and lesser ratings that have been great investments.
As a result I tend to group management teams on execution:
1) Underpromise and overdeliver
2) Do what they say
3) Overpromise and underdeliver
I'm always looking for 1 or 2. In this case, TMDX has mostly fallen into 1. They have consistently grown the business in a way that exceeds expectations. I obviously have no personal interaction with the CEO but have always been impressed with his laser focus on providing better patient outcomes and facilitating more transplants. I also know from first-hand experience working in truly high-standard environments is not for everyone and often falters in these types of rankings.
Ultimately, my responsibility to our portfolio is finding management teams that execute. While I want them to operate morally and ethically (for instance, I never entered TDOC because of past management scandals), whether or not they are likable falls further down my list. Others might feel differently, but that's the process I've settled on.
I hope that helps and am happy to hear any additional thoughts you might have.
Wow, you really could almost buy them outright now! I honestly don’t see anything else other than profit taking and am holding off on making a position until I see selling subside sufficiently.
Your thesis on TMDX has been interesting and has slowly converted my thinking on its prospects.
Congrats on the comeback month which always feels good after a rough month! I was wondering about CELH too as it seems like the only catalyst to the selling I can find is from profit taking after the stock split. Any thoughts or insights?
None that I can see. Good company with good prospects that just posted a good quarter. Maybe profit taking, but I can't see anything fundamentally wrong. I actually sold some $50 puts for next week a couple days ago that would get me shares under $49. Of course, I can almost buy them outright for that now.
Darned if I know on CELH. Good quarter, but it just didn't participate in this late run. I know it was mostly tech driven, but even ELF cosmetics was buoyed recently. I just know the business thesis for CELH seemed every bit intact out of the quarter.
Thanks for the feedback. The sample size was very small if you look at the glassdoor reviews over the past few years, so not exactly scientific. I don't obsess over glassdoor or indeed reviews or ratings but I like to look at it as a data point just to make sure it is not a red flag. As a Motley Fool and Phil Fisher acolyte, employee relations is always something that is in the back of my mind. Anyways, I just opened up a 2% starter position in TMDX. I like the MOAT, mission, and execution. I've watched from the sidelines for a while but the execution is impressive. Another question. What is your opinion of Jonah Lupton, if any? I've read a few of his articles on seeking alpha and recently subscribed to the free previews of his newsletter.
I follow Jonah on Twitter and have read a couple of his writeups, but it mostly been observation from afar. As an investor, he's a little too trading-heavy for my style (I'm not much into charts or hedging).
I am doing due diligence on transmedics and noticed poor glassdoor ratings, only 52% approved of the CEO and only 41% would recommend to a friend. Overall 2.7 stars. What is your opinion of employee relations and management?
Good question.
Over the years I've seen various people incorporate these types of rankings into their investment decisions. However, I've never been able to find a pattern that's actionable. I've owned companies with great approval ratings that have been terrible investments and lesser ratings that have been great investments.
As a result I tend to group management teams on execution:
1) Underpromise and overdeliver
2) Do what they say
3) Overpromise and underdeliver
I'm always looking for 1 or 2. In this case, TMDX has mostly fallen into 1. They have consistently grown the business in a way that exceeds expectations. I obviously have no personal interaction with the CEO but have always been impressed with his laser focus on providing better patient outcomes and facilitating more transplants. I also know from first-hand experience working in truly high-standard environments is not for everyone and often falters in these types of rankings.
Ultimately, my responsibility to our portfolio is finding management teams that execute. While I want them to operate morally and ethically (for instance, I never entered TDOC because of past management scandals), whether or not they are likable falls further down my list. Others might feel differently, but that's the process I've settled on.
I hope that helps and am happy to hear any additional thoughts you might have.
Wow, you really could almost buy them outright now! I honestly don’t see anything else other than profit taking and am holding off on making a position until I see selling subside sufficiently.
Your thesis on TMDX has been interesting and has slowly converted my thinking on its prospects.
Congrats on the comeback month which always feels good after a rough month! I was wondering about CELH too as it seems like the only catalyst to the selling I can find is from profit taking after the stock split. Any thoughts or insights?
None that I can see. Good company with good prospects that just posted a good quarter. Maybe profit taking, but I can't see anything fundamentally wrong. I actually sold some $50 puts for next week a couple days ago that would get me shares under $49. Of course, I can almost buy them outright for that now.
Congrats and best wishes for the Holidays to you and your loved ones.
Any thoughts on what is going on with CELH post-earnings? Why is the stock not getting any love if the report was so good?
Cheers!
Same to you.
Darned if I know on CELH. Good quarter, but it just didn't participate in this late run. I know it was mostly tech driven, but even ELF cosmetics was buoyed recently. I just know the business thesis for CELH seemed every bit intact out of the quarter.
Perhaps some nervousness about 2024 sales? I am not sure either. MStar FMV = $33. I think it is a good buy in the low $40s if it gets there.